Payment overview · 2025
General Payments
$36.86
2 reported records · 1 companies
Healthcare provider profile · identity verified
Charles E Brown, MD
Allopathic & Osteopathic Physicians|Internal Medicine · MEMPHIS, TN · NPI 1699880534
Verified facts
What the public records show
CMS Open Payments records show Charles E Brown, MD received $36.86 in general payments during 2025 across 2 reported records.
Abbott Laboratories accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Abbott Laboratories | Unresolved — no canonical attribution shown | $36.86 | 100.0% | 2 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $36.86 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| FREESTYLE LIBRE 3 Normalized: freestyle libre 3 |
Device | Abbott Laboratories | $36.86 | 2 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Amlodipine Besylate | Amlodipine Besylate | 916 | 298 |
| Atorvastatin Calcium | Atorvastatin Calcium | 708 | 248 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 323 | 117 |
| Pantoprazole Sodium | Pantoprazole Sodium | 320 | 116 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 318 | 114 |
| Gabapentin | Gabapentin | 297 | 106 |
| Furosemide | Furosemide | 293 | 111 |
| Losartan Potassium | Losartan Potassium | 282 | 96 |
| Omeprazole | Omeprazole | 259 | 98 |
| Carvedilol | Carvedilol | 255 | 98 |
| Potassium Chloride | Potassium Chloride | 243 | 86 |
| Hydralazine Hcl | Hydralazine Hcl | 239 | 80 |
| Metformin Hcl | Metformin Hcl | 233 | 79 |
| Metoprolol Tartrate | Metoprolol Tartrate | 215 | 72 |
| Fluticasone Propionate | Fluticasone Propionate | 204 | 103 |
| Lisinopril | Lisinopril | 189 | 65 |
| Metoprolol Succinate | Metoprolol Succinate | 185 | 56 |
| Tamsulosin Hcl | Tamsulosin Hcl | 182 | 64 |
| Montelukast Sodium | Montelukast Sodium | 175 | 57 |
| Levothyroxine Sodium | Levothyroxine Sodium | 166 | 48 |
| Tizanidine Hcl | Tizanidine Hcl | 159 | 66 |
| Alprazolam | Alprazolam | 148 | 29 |
| Metformin Hcl Er | Metformin Hcl | 146 | 52 |
| Hydrochlorothiazide | Hydrochlorothiazide | 144 | 53 |
| Clopidogrel | Clopidogrel Bisulfate | 138 | 51 |
| Diclofenac Sodium | Diclofenac Sodium | 137 | 51 |
| Methylprednisolone | Methylprednisolone | 137 | 118 |
| Famotidine | Famotidine | 132 | 49 |
| Allopurinol | Allopurinol | 124 | 42 |
| Jardiance | Empagliflozin | 122 | 40 |
| Eliquis | Apixaban | 117 | 36 |
| Meloxicam | Meloxicam | 109 | 44 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 108 | 35 |
| Tramadol Hcl | Tramadol Hcl | 107 | 42 |
| Glimepiride | Glimepiride | 106 | 37 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 104 | 32 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 103 | 51 |
| Ozempic | Semaglutide | 97 | 33 |
| Pravastatin Sodium | Pravastatin Sodium | 97 | 30 |
| Atenolol | Atenolol | 90 | 27 |
| Glipizide | Glipizide | 86 | 28 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 84 | 59 |
| Januvia | Sitagliptin Phosphate | 84 | 27 |
| Simvastatin | Simvastatin | 79 | 26 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 77 | 31 |
| Amoxicillin | Amoxicillin | 76 | 69 |
| Prednisone | Prednisone | 75 | 51 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 74 | 23 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 66 | 21 |
| Pregabalin | Pregabalin | 66 | 21 |
| Farxiga | Dapagliflozin Propanediol | 65 | 21 |
| Azithromycin | Azithromycin | 63 | 54 |
| Zolpidem Tartrate | Zolpidem Tartrate | 63 | 15 |
| Clonidine Hcl | Clonidine Hcl | 61 | 23 |
| Donepezil Hcl | Donepezil Hcl | 61 | 27 |
| Sertraline Hcl | Sertraline Hcl | 60 | 22 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 59 | 19 |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 57 | 18 |
| Benazepril Hcl | Benazepril Hcl | 56 | 18 |
| Nifedipine Er | Nifedipine | 56 | 17 |
| Duloxetine Hcl | Duloxetine Hcl | 53 | 20 |
| Trulicity | Dulaglutide | 51 | 14 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 48 | 19 |
| Amitriptyline Hcl | Amitriptyline Hcl | 46 | 17 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 46 | 42 |
| Trazodone Hcl | Trazodone Hcl | 44 | 20 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 43 | 17 |
| Colchicine | Colchicine | 42 | 17 |
| Ondansetron Odt | Ondansetron | 42 | suppressed |
| Methocarbamol | Methocarbamol | 40 | 20 |
| Symbicort | Budesonide/Formoterol Fumarate | 40 | 19 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 38 | 33 |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 35 | suppressed |
| Fluconazole | Fluconazole | 34 | 25 |
| Promethazine Hcl | Promethazine Hcl | 34 | suppressed |
| Ibuprofen | Ibuprofen | 33 | 18 |
| Ketoconazole | Ketoconazole | 33 | 21 |
| Lorazepam | Lorazepam | 32 | suppressed |
| Naproxen | Naproxen | 32 | 13 |
| Cefuroxime | Cefuroxime Axetil | 31 | 22 |
| Cyproheptadine Hcl | Cyproheptadine Hcl | 31 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 31 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 31 | 14 |
| Xarelto | Rivaroxaban | 31 | suppressed |
| Finasteride | Finasteride | 30 | 11 |
| Spironolactone | Spironolactone | 30 | 13 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 29 | 19 |
| Mounjaro | Tirzepatide | 29 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 28 | 16 |
| Topiramate | Topiramate | 28 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 26 | 11 |
| Fenofibrate | Fenofibrate Nanocrystallized | 26 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 25 | 20 |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 25 | suppressed |
| Fenofibrate | Fenofibrate | 24 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 24 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 23 | 14 |
| Chlorthalidone | Chlorthalidone | 23 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 23 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 23 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 23 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 22 | suppressed |
| Escitalopram Oxalate | Escitalopram Oxalate | 22 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 22 | suppressed |
| Novolin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 22 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 22 | 13 |
| Ezetimibe | Ezetimibe | 21 | 11 |
| Lactulose | Lactulose | 21 | 16 |
| Methimazole | Methimazole | 21 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 21 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 21 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 21 | suppressed |
| Glipizide-Metformin | Glipizide/Metformin Hcl | 20 | suppressed |
| Breyna | Budesonide/Formoterol Fumarate | 19 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 19 | suppressed |
| Levetiracetam | Levetiracetam | 19 | 11 |
| Atenolol-Chlorthalidone | Atenolol/Chlorthalidone | 18 | suppressed |
| Irbesartan | Irbesartan | 18 | suppressed |
| Levemir Flexpen | Insulin Detemir | 18 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 18 | suppressed |
| Amlodipine-Olmesartan | Amlodipine Bes/Olmesartan Med | 17 | suppressed |
| Humulin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 17 | suppressed |
| Memantine Hcl | Memantine Hcl | 17 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 17 | suppressed |
| Nitroglycerin | Nitroglycerin | 17 | suppressed |
| Olmesartan-Amlodipine-Hctz | Olmesartan/Amlodipin/Hcthiazid | 17 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 17 | suppressed |
| Fluticasone Propionate Hfa | Fluticasone Propionate | 16 | suppressed |
| Insulin Syringe | Syringe And Needle,insulin,1ml | 16 | suppressed |
| Lansoprazole | Lansoprazole | 16 | suppressed |
| Metronidazole | Metronidazole | 16 | 12 |
| Neomycin-Polymyxin-Hydrocort | Neomycin/Polymyxin B/Hydrocort | 16 | 13 |
| Paroxetine Hcl | Paroxetine Hcl | 16 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 16 | suppressed |
| Synthroid | Levothyroxine Sodium | 16 | suppressed |
| Temazepam | Temazepam | 16 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 16 | suppressed |
| Clonazepam | Clonazepam | 15 | suppressed |
| Eszopiclone | Eszopiclone | 15 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 15 | suppressed |
| Rizatriptan | Rizatriptan Benzoate | 15 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 14 | suppressed |
| Econazole Nitrate | Econazole Nitrate | 14 | suppressed |
| Klor-Con M20 | Potassium Chloride | 14 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 14 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 14 | suppressed |
| Entresto | Sacubitril/Valsartan | 13 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 13 | suppressed |
| Linzess | Linaclotide | 13 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 13 | suppressed |
| Niacin Er | Niacin | 13 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 13 | 13 |
| Tradjenta | Linagliptin | 13 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 13 | suppressed |
| Valsartan | Valsartan | 13 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 12 | suppressed |
| Bumetanide | Bumetanide | 12 | suppressed |
| Cephalexin | Cephalexin | 12 | 11 |
| Cilostazol | Cilostazol | 12 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 12 | suppressed |
| Myrbetriq | Mirabegron | 12 | suppressed |
| Pitavastatin Calcium | Pitavastatin Calcium | 12 | suppressed |
| Ramipril | Ramipril | 12 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 12 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 12 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 12 | suppressed |
| Acyclovir | Acyclovir | 11 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 11 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 11 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 11 | suppressed |
| Rybelsus | Semaglutide | 11 | suppressed |
| Torsemide | Torsemide | 11 | suppressed |
| Zaleplon | Zaleplon | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $36.86 · 2 records | Abbott Laboratories | FREESTYLE LIBRE 3 | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error